About Darshan February 6, 2020
Srividhya Ragavan is a Professor of Law at the Texas A&M School of Law and the Faculty Director of the School’s International Legal Studies Program.

Ragavan’s scholarship emphasizes issues intersecting international trade law with intellectual property rights

Ragavan’s books include Patents and Trade Disparities in Developing Countries (Oxford Univ. Press, 2012); Diversity in Intellectual Property: Identities, Interests, and Intersections (Eds., Calboli, Cambridge Univ. Press, 2019) and Intellectual Property Law and Access to Medicines (Eds., Vanni, Routledge 2021). The book was listed as one of Book Authority’s 12 Best New Intellectual Property Books to read in 2022. The book was also nominated by IPKat for the top ten Best IP Law books for 2021. 

Sri Ragavan has been regularly featured in op-eds in several media

Sri Ragavan has been regularly featured in op-eds in several media including the New York Times, Fortune Magazine and foreign media such as TBS eFM’s “This Morning”, an all-English current affairs program in Seoul. Similarly, she has been featured in Hindu Business Line, The Hindu, DNA, LiveMint and also the All India Radio.

She has testified in support of India’s position involving access to medication issues with the US International Trade Commission and at the Office of the US Trade Representative. Ragavan is a regular speaker in forums that include academics, government officials and most importantly policy makers from the World Trade Organization (WTO), the World Health Organization (WHO) and the World Intellectual Property Association (WIPO).  She was engaged as a specialist reviewer/consultant for the WIPO.
 
Sri Ragavan has been regularly featured in op-eds in several media

Sri Ragavan has been regularly featured in op-eds in several media including the New York Times, Fortune Magazine and foreign media such as TBS eFM’s “This Morning”, an all-English current affairs program in Seoul. Similarly, she has been featured in Hindu Business Line, The Hindu, DNA, LiveMint and also the All India Radio.

She has testified in support of India’s position involving access to medication issues with the US International Trade Commission and at the Office of the US Trade Representative. Ragavan is a regular speaker in forums that include academics, government officials and most importantly policy makers from the World Trade Organization (WTO), the World Health Organization (WHO) and the World Intellectual Property Association (WIPO).  She was engaged as a specialist reviewer/consultant for the WIPO.